Study of WAL0921 in Patients With Glomerular Kidney Diseases
Conditions
Diabetic Nephropathies · Primary Focal Segmental Glomerulosclerosis · Minimal Change Disease · Primary Immunoglobulin A Nephropathy · Primary Membranous Nephropathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Academic Medical Research Institute, Los Angeles, California, United States
Colorado Kidney and Vascular Care, Denver, Colorado, United States
D & H Tamarac Research Center, Tamarac, Florida, United States
Fides Clinical Research, Atlanta, Georgia, United States
Nephrology Associates of Northern Illinois and Indiana (NANI), Hinsdale, Illinois, United States
Dunes Clinical Research, Dakota Dunes, South Dakota, United States
Prolato Clinical Research Center, Houston, Texas, United States
Clinical Trial Network, Houston, Texas, United States
Clinical Advancement Center, San Antonio, Texas, United States
Westmead Hospital, Westmead, New South Wales, Australia
Western Health Sunshine Hospital, St Albans, Victoria, Australia
AIIMS Hospital, Raipur, Chhattisgarh, India
Muljibhai Patel Urological Hospital, Nadiād, Gujarat, India
Dhiraj Hospital, Vadodara, Gujarat, India
MS Ramaiah Medical College and Hospitals, Bangalore, Karnataka, India
Mazumdar Shah Medical Center, Bangalore, Karnataka, India
Manipal Hospital, Pune, Maharashtra, India
MGM Medical Care and Hospital, Sambhajinagar, Maharashtra, India
Sir Ganga Ram Hospital, New Delhi, National Capital Territory of Delhi, India
Max Super Speciality Hospital, Patparganj, National Capital Territory of Delhi, India
SUM Hospital, Bhubaneswar, Odisha, India
SMS Medical College and Hospital, Jaipur, Rajasthan, India
Osmania General Hospital, Hyderabad, Telangana, India
Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
Nutema Hospital, Meerut, Uttar Pradesh, India
Shri Guru Ram Rai Institute of Medical and Health Sciences, Dehradun, Uttarakhand, India
NRS Medical College and Hospital Kolkata, Kolkata, West Bengal, India
Hospital Canselor Tuanku Muhriz UKM, Cheras, Kuala Lumpur, Malaysia
Hospital Kuala Lumpur, Kuala Lumpur, Kuala Lumpur, Malaysia
University Malaya Medical Centre, Kuala Lumpur, Kuala Lumpur, Malaysia
Hospital Tengku Ampuan Afzan, Kuantan, Pahang, Malaysia
Hospital Sultan Idris Shah Serdang, Kajang, Selangor, Malaysia
Sunway Medical Centre, Petaling Jaya, Selangor, Malaysia
Hallym University Sacred Heart Hospital, Anyang, South Korea
Pusan National University Hospital, Busan, South Korea
Seoul National University Bundang Hospital, Seongnam-si, South Korea
Severance Hospital - Yonsei Cancer Center, Seoul, South Korea
Samsung Medical Center, Soeul, South Korea
Ajou University Hospital, Suwon, South Korea
National Hospital of Sri Lanka, Colombo, Sri Lanka
Jaffna Teaching Hospital, Jaffna, Sri Lanka
Kandy National Hospital, Kandy, Sri Lanka
Kurunegala Teaching Hospital, Kurunegala, Sri Lanka
Kothalawala Defence University Hospital, Werahera, Sri Lanka
Royal Derby Hospital, Derby, United Kingdom
Contact: Study coordinator (Michelle Skupian) · clinicaltrials@waldenbiosciences.com · +1 857 314 1961College of Life Sciences, University of Leicester, Leicester, United Kingdom
Contact: Study coordinator (Michelle Skupian)Barts Health NHS Trust, London, United Kingdom
Contact: Study coordinator (Michelle Skupian)Manchester University NHS Foundation Trust, Manchester, United Kingdom
Contact: Study coordinator (Michelle Skupian)Salford Royal NHS Foundation Trust, Salford, United Kingdom
Contact: Study coordinator (michelle Skupian)
Study leads
Andrew Blair, MD
Study Director
Walden Biosciences